| __timestamp | CRISPR Therapeutics AG | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 56369000000 |
| Thursday, January 1, 2015 | 12573000 | 62786000000 |
| Friday, January 1, 2016 | 42238000 | 62427000000 |
| Sunday, January 1, 2017 | 69800000 | 62453000000 |
| Monday, January 1, 2018 | 113773000 | 65724000000 |
| Tuesday, January 1, 2019 | 179362000 | 70421000000 |
| Wednesday, January 1, 2020 | 269407000 | 80591000000 |
| Friday, January 1, 2021 | 17953000 | 86645000000 |
| Saturday, January 1, 2022 | 110250000 | 100551000000 |
| Sunday, January 1, 2023 | 130250000 | 42907000000 |
| Monday, January 1, 2024 | -2314000 | 115557000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, cost efficiency is a critical metric for success. This analysis delves into the cost of revenue trends for Dr. Reddy's Laboratories Limited and CRISPR Therapeutics AG from 2014 to 2023. Dr. Reddy's, a stalwart in the industry, consistently reported a cost of revenue exceeding $60 billion annually, peaking at $115 billion in 2024. In contrast, CRISPR Therapeutics, a pioneer in gene editing, showed a more volatile pattern, with costs ranging from $1.5 million in 2014 to $269 million in 2020. Notably, CRISPR's costs surged by over 17,000% from 2014 to 2020, reflecting its rapid growth and investment in cutting-edge technology. Meanwhile, Dr. Reddy's demonstrated a steady increase, with a 78% rise over the same period. The data for 2024 is incomplete for CRISPR, highlighting the dynamic nature of this sector.
Johnson & Johnson vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: GSK plc vs CRISPR Therapeutics AG
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Exelixis, Inc. and CRISPR Therapeutics AG
Cost of Revenue: Key Insights for Pharming Group N.V. and CRISPR Therapeutics AG
Analyzing Cost of Revenue: Cytokinetics, Incorporated and CRISPR Therapeutics AG